Global Submucosal Injection Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Submucosal Injection Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 99

Published Date: 29 Jun 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Submucosal Injection Agent market size was valued at USD 100.3 million in 2022 and is forecast to a readjusted size of USD 164.6 million by 2029 with a CAGR of 7.3% during review period.

Submucosal Injection Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.

It facilitates endoscopic resection procedures during endoscopic examinations in the upper and lower gastrointestinal tract, such as the esophagus, the stomach.

The global top five submucosal injection agent manufacturers include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, accounting for more than 60% of the market share, of which the largest manufacturer is Seikagaku, with a market share of more than 18%. North America is the most important submucosal injection agent consumer market in the world, with a market share of more than 32%. In terms of type, the market share of syringe type is more than 90%. In the application field, the market share of hospitals has reached more than 60%.

The Global Info Research report includes an overview of the development of the Submucosal Injection Agent industry chain, the market status of Hospitals (Syringe Type, Ampoule Type), Ambulatory Surgical Centers (Syringe Type, Ampoule Type), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Submucosal Injection Agent.

Regionally, the report analyzes the Submucosal Injection Agent markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Submucosal Injection Agent market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Submucosal Injection Agent market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Submucosal Injection Agent industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Syringe Type, Ampoule Type).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Submucosal Injection Agent market.

Regional Analysis: The report involves examining the Submucosal Injection Agent market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Submucosal Injection Agent market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Submucosal Injection Agent:
Company Analysis: Report covers individual Submucosal Injection Agent manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Submucosal Injection Agent This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).

Technology Analysis: Report covers specific technologies relevant to Submucosal Injection Agent. It assesses the current state, advancements, and potential future developments in Submucosal Injection Agent areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Submucosal Injection Agent market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Submucosal Injection Agent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Syringe Type
Ampoule Type

Market segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Major players covered
Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Submucosal Injection Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Submucosal Injection Agent, with price, sales, revenue and global market share of Submucosal Injection Agent from 2018 to 2023.
Chapter 3, the Submucosal Injection Agent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Submucosal Injection Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Submucosal Injection Agent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Submucosal Injection Agent.
Chapter 14 and 15, to describe Submucosal Injection Agent sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Submucosal Injection Agent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Submucosal Injection Agent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringe Type
1.3.3 Ampoule Type
1.4 Market Analysis by Application
1.4.1 Overview: Global Submucosal Injection Agent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Specialty Clinics
1.5 Global Submucosal Injection Agent Market Size & Forecast
1.5.1 Global Submucosal Injection Agent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Submucosal Injection Agent Sales Quantity (2018-2029)
1.5.3 Global Submucosal Injection Agent Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Seikagaku
2.1.1 Seikagaku Details
2.1.2 Seikagaku Major Business
2.1.3 Seikagaku Submucosal Injection Agent Product and Services
2.1.4 Seikagaku Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Seikagaku Recent Developments/Updates
2.2 Ovesco Endoscopy
2.2.1 Ovesco Endoscopy Details
2.2.2 Ovesco Endoscopy Major Business
2.2.3 Ovesco Endoscopy Submucosal Injection Agent Product and Services
2.2.4 Ovesco Endoscopy Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ovesco Endoscopy Recent Developments/Updates
2.3 GI Supply
2.3.1 GI Supply Details
2.3.2 GI Supply Major Business
2.3.3 GI Supply Submucosal Injection Agent Product and Services
2.3.4 GI Supply Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GI Supply Recent Developments/Updates
2.4 Cosmo Pharmaceuticals
2.4.1 Cosmo Pharmaceuticals Details
2.4.2 Cosmo Pharmaceuticals Major Business
2.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Product and Services
2.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Submucosal Injection Agent Product and Services
2.5.4 Boston Scientific Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boston Scientific Recent Developments/Updates
2.6 The Standard
2.6.1 The Standard Details
2.6.2 The Standard Major Business
2.6.3 The Standard Submucosal Injection Agent Product and Services
2.6.4 The Standard Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 The Standard Recent Developments/Updates
2.7 Micro-Tech Endoscopy
2.7.1 Micro-Tech Endoscopy Details
2.7.2 Micro-Tech Endoscopy Major Business
2.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Product and Services
2.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Micro-Tech Endoscopy Recent Developments/Updates
2.8 EndoClot Plus
2.8.1 EndoClot Plus Details
2.8.2 EndoClot Plus Major Business
2.8.3 EndoClot Plus Submucosal Injection Agent Product and Services
2.8.4 EndoClot Plus Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 EndoClot Plus Recent Developments/Updates

3 Competitive Environment: Submucosal Injection Agent by Manufacturer
3.1 Global Submucosal Injection Agent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Submucosal Injection Agent Revenue by Manufacturer (2018-2023)
3.3 Global Submucosal Injection Agent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Submucosal Injection Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Submucosal Injection Agent Manufacturer Market Share in 2022
3.4.2 Top 6 Submucosal Injection Agent Manufacturer Market Share in 2022
3.5 Submucosal Injection Agent Market: Overall Company Footprint Analysis
3.5.1 Submucosal Injection Agent Market: Region Footprint
3.5.2 Submucosal Injection Agent Market: Company Product Type Footprint
3.5.3 Submucosal Injection Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Submucosal Injection Agent Market Size by Region
4.1.1 Global Submucosal Injection Agent Sales Quantity by Region (2018-2029)
4.1.2 Global Submucosal Injection Agent Consumption Value by Region (2018-2029)
4.1.3 Global Submucosal Injection Agent Average Price by Region (2018-2029)
4.2 North America Submucosal Injection Agent Consumption Value (2018-2029)
4.3 Europe Submucosal Injection Agent Consumption Value (2018-2029)
4.4 Asia-Pacific Submucosal Injection Agent Consumption Value (2018-2029)
4.5 South America Submucosal Injection Agent Consumption Value (2018-2029)
4.6 Middle East and Africa Submucosal Injection Agent Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Submucosal Injection Agent Sales Quantity by Type (2018-2029)
5.2 Global Submucosal Injection Agent Consumption Value by Type (2018-2029)
5.3 Global Submucosal Injection Agent Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Submucosal Injection Agent Sales Quantity by Application (2018-2029)
6.2 Global Submucosal Injection Agent Consumption Value by Application (2018-2029)
6.3 Global Submucosal Injection Agent Average Price by Application (2018-2029)

7 North America
7.1 North America Submucosal Injection Agent Sales Quantity by Type (2018-2029)
7.2 North America Submucosal Injection Agent Sales Quantity by Application (2018-2029)
7.3 North America Submucosal Injection Agent Market Size by Country
7.3.1 North America Submucosal Injection Agent Sales Quantity by Country (2018-2029)
7.3.2 North America Submucosal Injection Agent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Submucosal Injection Agent Sales Quantity by Type (2018-2029)
8.2 Europe Submucosal Injection Agent Sales Quantity by Application (2018-2029)
8.3 Europe Submucosal Injection Agent Market Size by Country
8.3.1 Europe Submucosal Injection Agent Sales Quantity by Country (2018-2029)
8.3.2 Europe Submucosal Injection Agent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Submucosal Injection Agent Market Size by Region
9.3.1 Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Submucosal Injection Agent Sales Quantity by Type (2018-2029)
10.2 South America Submucosal Injection Agent Sales Quantity by Application (2018-2029)
10.3 South America Submucosal Injection Agent Market Size by Country
10.3.1 South America Submucosal Injection Agent Sales Quantity by Country (2018-2029)
10.3.2 South America Submucosal Injection Agent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Submucosal Injection Agent Market Size by Country
11.3.1 Middle East & Africa Submucosal Injection Agent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Submucosal Injection Agent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Submucosal Injection Agent Market Drivers
12.2 Submucosal Injection Agent Market Restraints
12.3 Submucosal Injection Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Submucosal Injection Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Submucosal Injection Agent
13.3 Submucosal Injection Agent Production Process
13.4 Submucosal Injection Agent Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Submucosal Injection Agent Typical Distributors
14.3 Submucosal Injection Agent Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Submucosal Injection Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Submucosal Injection Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Seikagaku Basic Information, Manufacturing Base and Competitors
Table 4. Seikagaku Major Business
Table 5. Seikagaku Submucosal Injection Agent Product and Services
Table 6. Seikagaku Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Seikagaku Recent Developments/Updates
Table 8. Ovesco Endoscopy Basic Information, Manufacturing Base and Competitors
Table 9. Ovesco Endoscopy Major Business
Table 10. Ovesco Endoscopy Submucosal Injection Agent Product and Services
Table 11. Ovesco Endoscopy Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ovesco Endoscopy Recent Developments/Updates
Table 13. GI Supply Basic Information, Manufacturing Base and Competitors
Table 14. GI Supply Major Business
Table 15. GI Supply Submucosal Injection Agent Product and Services
Table 16. GI Supply Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GI Supply Recent Developments/Updates
Table 18. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Cosmo Pharmaceuticals Major Business
Table 20. Cosmo Pharmaceuticals Submucosal Injection Agent Product and Services
Table 21. Cosmo Pharmaceuticals Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Cosmo Pharmaceuticals Recent Developments/Updates
Table 23. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 24. Boston Scientific Major Business
Table 25. Boston Scientific Submucosal Injection Agent Product and Services
Table 26. Boston Scientific Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Boston Scientific Recent Developments/Updates
Table 28. The Standard Basic Information, Manufacturing Base and Competitors
Table 29. The Standard Major Business
Table 30. The Standard Submucosal Injection Agent Product and Services
Table 31. The Standard Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. The Standard Recent Developments/Updates
Table 33. Micro-Tech Endoscopy Basic Information, Manufacturing Base and Competitors
Table 34. Micro-Tech Endoscopy Major Business
Table 35. Micro-Tech Endoscopy Submucosal Injection Agent Product and Services
Table 36. Micro-Tech Endoscopy Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Micro-Tech Endoscopy Recent Developments/Updates
Table 38. EndoClot Plus Basic Information, Manufacturing Base and Competitors
Table 39. EndoClot Plus Major Business
Table 40. EndoClot Plus Submucosal Injection Agent Product and Services
Table 41. EndoClot Plus Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. EndoClot Plus Recent Developments/Updates
Table 43. Global Submucosal Injection Agent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global Submucosal Injection Agent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Submucosal Injection Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in Submucosal Injection Agent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Submucosal Injection Agent Production Site of Key Manufacturer
Table 48. Submucosal Injection Agent Market: Company Product Type Footprint
Table 49. Submucosal Injection Agent Market: Company Product Application Footprint
Table 50. Submucosal Injection Agent New Market Entrants and Barriers to Market Entry
Table 51. Submucosal Injection Agent Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Submucosal Injection Agent Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global Submucosal Injection Agent Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global Submucosal Injection Agent Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Submucosal Injection Agent Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Submucosal Injection Agent Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global Submucosal Injection Agent Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global Submucosal Injection Agent Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Submucosal Injection Agent Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Submucosal Injection Agent Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global Submucosal Injection Agent Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Submucosal Injection Agent Raw Material
Table 111. Key Manufacturers of Submucosal Injection Agent Raw Materials
Table 112. Submucosal Injection Agent Typical Distributors
Table 113. Submucosal Injection Agent Typical Customers
List of Figures
Figure 1. Submucosal Injection Agent Picture
Figure 2. Global Submucosal Injection Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Submucosal Injection Agent Consumption Value Market Share by Type in 2022
Figure 4. Syringe Type Examples
Figure 5. Ampoule Type Examples
Figure 6. Global Submucosal Injection Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Submucosal Injection Agent Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Ambulatory Surgical Centers Examples
Figure 10. Specialty Clinics Examples
Figure 11. Global Submucosal Injection Agent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Submucosal Injection Agent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Submucosal Injection Agent Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Submucosal Injection Agent Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Submucosal Injection Agent Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Submucosal Injection Agent Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Submucosal Injection Agent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Submucosal Injection Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Submucosal Injection Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Submucosal Injection Agent Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Submucosal Injection Agent Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Submucosal Injection Agent Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Submucosal Injection Agent Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 53. China Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Submucosal Injection Agent Market Drivers
Figure 74. Submucosal Injection Agent Market Restraints
Figure 75. Submucosal Injection Agent Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Submucosal Injection Agent in 2022
Figure 78. Manufacturing Process Analysis of Submucosal Injection Agent
Figure 79. Submucosal Injection Agent Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Submucosal Injection Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Submucosal Injection Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 99

Published Date: 29 Jun 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Submucosal Injection Agent market size was valued at USD 100.3 million in 2022 and is forecast to a readjusted size of USD 164.6 million by 2029 with a CAGR of 7.3% during review period.

Submucosal Injection Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.

It facilitates endoscopic resection procedures during endoscopic examinations in the upper and lower gastrointestinal tract, such as the esophagus, the stomach.

The global top five submucosal injection agent manufacturers include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, accounting for more than 60% of the market share, of which the largest manufacturer is Seikagaku, with a market share of more than 18%. North America is the most important submucosal injection agent consumer market in the world, with a market share of more than 32%. In terms of type, the market share of syringe type is more than 90%. In the application field, the market share of hospitals has reached more than 60%.

The Global Info Research report includes an overview of the development of the Submucosal Injection Agent industry chain, the market status of Hospitals (Syringe Type, Ampoule Type), Ambulatory Surgical Centers (Syringe Type, Ampoule Type), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Submucosal Injection Agent.

Regionally, the report analyzes the Submucosal Injection Agent markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Submucosal Injection Agent market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Submucosal Injection Agent market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Submucosal Injection Agent industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Syringe Type, Ampoule Type).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Submucosal Injection Agent market.

Regional Analysis: The report involves examining the Submucosal Injection Agent market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Submucosal Injection Agent market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Submucosal Injection Agent:
Company Analysis: Report covers individual Submucosal Injection Agent manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Submucosal Injection Agent This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).

Technology Analysis: Report covers specific technologies relevant to Submucosal Injection Agent. It assesses the current state, advancements, and potential future developments in Submucosal Injection Agent areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Submucosal Injection Agent market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Submucosal Injection Agent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Syringe Type
Ampoule Type

Market segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Major players covered
Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Submucosal Injection Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Submucosal Injection Agent, with price, sales, revenue and global market share of Submucosal Injection Agent from 2018 to 2023.
Chapter 3, the Submucosal Injection Agent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Submucosal Injection Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Submucosal Injection Agent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Submucosal Injection Agent.
Chapter 14 and 15, to describe Submucosal Injection Agent sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Submucosal Injection Agent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Submucosal Injection Agent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringe Type
1.3.3 Ampoule Type
1.4 Market Analysis by Application
1.4.1 Overview: Global Submucosal Injection Agent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Specialty Clinics
1.5 Global Submucosal Injection Agent Market Size & Forecast
1.5.1 Global Submucosal Injection Agent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Submucosal Injection Agent Sales Quantity (2018-2029)
1.5.3 Global Submucosal Injection Agent Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Seikagaku
2.1.1 Seikagaku Details
2.1.2 Seikagaku Major Business
2.1.3 Seikagaku Submucosal Injection Agent Product and Services
2.1.4 Seikagaku Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Seikagaku Recent Developments/Updates
2.2 Ovesco Endoscopy
2.2.1 Ovesco Endoscopy Details
2.2.2 Ovesco Endoscopy Major Business
2.2.3 Ovesco Endoscopy Submucosal Injection Agent Product and Services
2.2.4 Ovesco Endoscopy Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ovesco Endoscopy Recent Developments/Updates
2.3 GI Supply
2.3.1 GI Supply Details
2.3.2 GI Supply Major Business
2.3.3 GI Supply Submucosal Injection Agent Product and Services
2.3.4 GI Supply Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GI Supply Recent Developments/Updates
2.4 Cosmo Pharmaceuticals
2.4.1 Cosmo Pharmaceuticals Details
2.4.2 Cosmo Pharmaceuticals Major Business
2.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Product and Services
2.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Submucosal Injection Agent Product and Services
2.5.4 Boston Scientific Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boston Scientific Recent Developments/Updates
2.6 The Standard
2.6.1 The Standard Details
2.6.2 The Standard Major Business
2.6.3 The Standard Submucosal Injection Agent Product and Services
2.6.4 The Standard Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 The Standard Recent Developments/Updates
2.7 Micro-Tech Endoscopy
2.7.1 Micro-Tech Endoscopy Details
2.7.2 Micro-Tech Endoscopy Major Business
2.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Product and Services
2.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Micro-Tech Endoscopy Recent Developments/Updates
2.8 EndoClot Plus
2.8.1 EndoClot Plus Details
2.8.2 EndoClot Plus Major Business
2.8.3 EndoClot Plus Submucosal Injection Agent Product and Services
2.8.4 EndoClot Plus Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 EndoClot Plus Recent Developments/Updates

3 Competitive Environment: Submucosal Injection Agent by Manufacturer
3.1 Global Submucosal Injection Agent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Submucosal Injection Agent Revenue by Manufacturer (2018-2023)
3.3 Global Submucosal Injection Agent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Submucosal Injection Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Submucosal Injection Agent Manufacturer Market Share in 2022
3.4.2 Top 6 Submucosal Injection Agent Manufacturer Market Share in 2022
3.5 Submucosal Injection Agent Market: Overall Company Footprint Analysis
3.5.1 Submucosal Injection Agent Market: Region Footprint
3.5.2 Submucosal Injection Agent Market: Company Product Type Footprint
3.5.3 Submucosal Injection Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Submucosal Injection Agent Market Size by Region
4.1.1 Global Submucosal Injection Agent Sales Quantity by Region (2018-2029)
4.1.2 Global Submucosal Injection Agent Consumption Value by Region (2018-2029)
4.1.3 Global Submucosal Injection Agent Average Price by Region (2018-2029)
4.2 North America Submucosal Injection Agent Consumption Value (2018-2029)
4.3 Europe Submucosal Injection Agent Consumption Value (2018-2029)
4.4 Asia-Pacific Submucosal Injection Agent Consumption Value (2018-2029)
4.5 South America Submucosal Injection Agent Consumption Value (2018-2029)
4.6 Middle East and Africa Submucosal Injection Agent Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Submucosal Injection Agent Sales Quantity by Type (2018-2029)
5.2 Global Submucosal Injection Agent Consumption Value by Type (2018-2029)
5.3 Global Submucosal Injection Agent Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Submucosal Injection Agent Sales Quantity by Application (2018-2029)
6.2 Global Submucosal Injection Agent Consumption Value by Application (2018-2029)
6.3 Global Submucosal Injection Agent Average Price by Application (2018-2029)

7 North America
7.1 North America Submucosal Injection Agent Sales Quantity by Type (2018-2029)
7.2 North America Submucosal Injection Agent Sales Quantity by Application (2018-2029)
7.3 North America Submucosal Injection Agent Market Size by Country
7.3.1 North America Submucosal Injection Agent Sales Quantity by Country (2018-2029)
7.3.2 North America Submucosal Injection Agent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Submucosal Injection Agent Sales Quantity by Type (2018-2029)
8.2 Europe Submucosal Injection Agent Sales Quantity by Application (2018-2029)
8.3 Europe Submucosal Injection Agent Market Size by Country
8.3.1 Europe Submucosal Injection Agent Sales Quantity by Country (2018-2029)
8.3.2 Europe Submucosal Injection Agent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Submucosal Injection Agent Market Size by Region
9.3.1 Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Submucosal Injection Agent Sales Quantity by Type (2018-2029)
10.2 South America Submucosal Injection Agent Sales Quantity by Application (2018-2029)
10.3 South America Submucosal Injection Agent Market Size by Country
10.3.1 South America Submucosal Injection Agent Sales Quantity by Country (2018-2029)
10.3.2 South America Submucosal Injection Agent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Submucosal Injection Agent Market Size by Country
11.3.1 Middle East & Africa Submucosal Injection Agent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Submucosal Injection Agent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Submucosal Injection Agent Market Drivers
12.2 Submucosal Injection Agent Market Restraints
12.3 Submucosal Injection Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Submucosal Injection Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Submucosal Injection Agent
13.3 Submucosal Injection Agent Production Process
13.4 Submucosal Injection Agent Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Submucosal Injection Agent Typical Distributors
14.3 Submucosal Injection Agent Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Submucosal Injection Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Submucosal Injection Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Seikagaku Basic Information, Manufacturing Base and Competitors
Table 4. Seikagaku Major Business
Table 5. Seikagaku Submucosal Injection Agent Product and Services
Table 6. Seikagaku Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Seikagaku Recent Developments/Updates
Table 8. Ovesco Endoscopy Basic Information, Manufacturing Base and Competitors
Table 9. Ovesco Endoscopy Major Business
Table 10. Ovesco Endoscopy Submucosal Injection Agent Product and Services
Table 11. Ovesco Endoscopy Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ovesco Endoscopy Recent Developments/Updates
Table 13. GI Supply Basic Information, Manufacturing Base and Competitors
Table 14. GI Supply Major Business
Table 15. GI Supply Submucosal Injection Agent Product and Services
Table 16. GI Supply Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GI Supply Recent Developments/Updates
Table 18. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Cosmo Pharmaceuticals Major Business
Table 20. Cosmo Pharmaceuticals Submucosal Injection Agent Product and Services
Table 21. Cosmo Pharmaceuticals Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Cosmo Pharmaceuticals Recent Developments/Updates
Table 23. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 24. Boston Scientific Major Business
Table 25. Boston Scientific Submucosal Injection Agent Product and Services
Table 26. Boston Scientific Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Boston Scientific Recent Developments/Updates
Table 28. The Standard Basic Information, Manufacturing Base and Competitors
Table 29. The Standard Major Business
Table 30. The Standard Submucosal Injection Agent Product and Services
Table 31. The Standard Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. The Standard Recent Developments/Updates
Table 33. Micro-Tech Endoscopy Basic Information, Manufacturing Base and Competitors
Table 34. Micro-Tech Endoscopy Major Business
Table 35. Micro-Tech Endoscopy Submucosal Injection Agent Product and Services
Table 36. Micro-Tech Endoscopy Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Micro-Tech Endoscopy Recent Developments/Updates
Table 38. EndoClot Plus Basic Information, Manufacturing Base and Competitors
Table 39. EndoClot Plus Major Business
Table 40. EndoClot Plus Submucosal Injection Agent Product and Services
Table 41. EndoClot Plus Submucosal Injection Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. EndoClot Plus Recent Developments/Updates
Table 43. Global Submucosal Injection Agent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global Submucosal Injection Agent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Submucosal Injection Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 46. Market Position of Manufacturers in Submucosal Injection Agent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Submucosal Injection Agent Production Site of Key Manufacturer
Table 48. Submucosal Injection Agent Market: Company Product Type Footprint
Table 49. Submucosal Injection Agent Market: Company Product Application Footprint
Table 50. Submucosal Injection Agent New Market Entrants and Barriers to Market Entry
Table 51. Submucosal Injection Agent Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Submucosal Injection Agent Average Price by Region (2018-2023) & (US$/Unit)
Table 57. Global Submucosal Injection Agent Average Price by Region (2024-2029) & (US$/Unit)
Table 58. Global Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global Submucosal Injection Agent Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Submucosal Injection Agent Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Submucosal Injection Agent Average Price by Type (2018-2023) & (US$/Unit)
Table 63. Global Submucosal Injection Agent Average Price by Type (2024-2029) & (US$/Unit)
Table 64. Global Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global Submucosal Injection Agent Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Submucosal Injection Agent Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Submucosal Injection Agent Average Price by Application (2018-2023) & (US$/Unit)
Table 69. Global Submucosal Injection Agent Average Price by Application (2024-2029) & (US$/Unit)
Table 70. North America Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America Submucosal Injection Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America Submucosal Injection Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America Submucosal Injection Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Submucosal Injection Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa Submucosal Injection Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa Submucosal Injection Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa Submucosal Injection Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Submucosal Injection Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Submucosal Injection Agent Raw Material
Table 111. Key Manufacturers of Submucosal Injection Agent Raw Materials
Table 112. Submucosal Injection Agent Typical Distributors
Table 113. Submucosal Injection Agent Typical Customers
List of Figures
Figure 1. Submucosal Injection Agent Picture
Figure 2. Global Submucosal Injection Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Submucosal Injection Agent Consumption Value Market Share by Type in 2022
Figure 4. Syringe Type Examples
Figure 5. Ampoule Type Examples
Figure 6. Global Submucosal Injection Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Submucosal Injection Agent Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Ambulatory Surgical Centers Examples
Figure 10. Specialty Clinics Examples
Figure 11. Global Submucosal Injection Agent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Submucosal Injection Agent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Submucosal Injection Agent Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Submucosal Injection Agent Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Submucosal Injection Agent Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Submucosal Injection Agent Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Submucosal Injection Agent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Submucosal Injection Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Submucosal Injection Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Submucosal Injection Agent Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Submucosal Injection Agent Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Submucosal Injection Agent Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Submucosal Injection Agent Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Submucosal Injection Agent Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 53. China Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Submucosal Injection Agent Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Submucosal Injection Agent Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Submucosal Injection Agent Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Submucosal Injection Agent Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Submucosal Injection Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Submucosal Injection Agent Market Drivers
Figure 74. Submucosal Injection Agent Market Restraints
Figure 75. Submucosal Injection Agent Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Submucosal Injection Agent in 2022
Figure 78. Manufacturing Process Analysis of Submucosal Injection Agent
Figure 79. Submucosal Injection Agent Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus
jiaGou

Add To Cart

gouMai

Buy Now